HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.

Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the most frequently diagnosed cancers in China, but the etiology and mode of carcinogenesis of this disease remain poorly understood. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), as a negative regulator of Akt/mTOR pathway, frequently mutates or is inactive in many cancers. Although mTOR has been thought a promising cancer therapeutic target, the sensitivity of tumor cells to rapamycin was still to be revaluated. In this study, we measured the effects of rapamycin on cell proliferation and phosphorylation of Akt in ESCC cells with varying degrees of differentiation. And then, the relationship between PTEN status and the sensitivity of cells to rapamycin was investigated in EC9706 cells with or without wild-type PTEN in vitro and in vivo. The results demonstrated ESCC cells with poor differentiation were insensitive to rapamycin of high concentration and rapamycin obviously promoted the phosphorylation of Akt in these cells, but it had no obvious effects on p-Akt in cells with well differentiation. Also, we showed that wild-type PTEN improved the sensitivity of poor differentiation cells to rapamycin through inhibiting phosphorylation of Akt in vitro and in vivo. This study explored the possible molecular mechanism of some ESCC cells insensitive to rapamycin and provided a measure for treating ESCC patients with PTEN inactivation using mTOR inhibitors.
AuthorsZ Lu, J Wang, Y Zheng, S Yang, M Liu, X Chen, C Wang, G Hou
JournalDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus (Dis Esophagus) Vol. 30 Issue 2 Pg. 1-8 (02 01 2017) ISSN: 1442-2050 [Electronic] United States
PMID26725440 (Publication Type: Journal Article)
Copyright© 2015 International Society for Diseases of the Esophagus.
Chemical References
  • Antibiotics, Antineoplastic
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • PTEN Phosphohydrolase
  • Pten protein, mouse
  • Sirolimus
Topics
  • Animals
  • Antibiotics, Antineoplastic (pharmacology)
  • Carcinoma, Squamous Cell (drug therapy, genetics)
  • Cell Differentiation (drug effects, genetics)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Resistance, Neoplasm
  • Esophageal Neoplasms (drug therapy, genetics)
  • Esophageal Squamous Cell Carcinoma
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • PTEN Phosphohydrolase (drug effects, genetics)
  • Pharmacogenetics
  • Phosphorylation (drug effects, genetics)
  • Proto-Oncogene Proteins c-akt (drug effects, metabolism)
  • Random Allocation
  • Signal Transduction (drug effects, genetics)
  • Sirolimus (pharmacology)
  • TOR Serine-Threonine Kinases (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: